A carregar...
Brexpiprazole: A New Treatment Option for Schizophrenia
Schizophrenia occurs in approximately 0.3 to 0.7 percent of the world’s population and is associated with significant morbidity and mortality. Although atypical antipsychotics reduce positive and negative symptoms, they are associated with varying degrees of metabolic adverse effects. This necessita...
Na minha lista:
| Publicado no: | Innov Clin Neurosci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Matrix Medical Communications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5022986/ https://ncbi.nlm.nih.gov/pubmed/27672485 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|